These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20699333)

  • 21. Verification of surface contamination of Japanese cyclophosphamide vials and an example of exposure by handling.
    Hama K; Fukushima K; Hirabatake M; Hashida T; Kataoka K
    J Oncol Pharm Pract; 2012 Jun; 18(2):201-6. PubMed ID: 21947739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of environmental contaminations and occupational exposures involved in preparation of chemotherapeutic drugs.
    Maeda S; Miyawaki K; Matsumoto S; Oishi M; Miwa Y; Kurokawa N
    Yakugaku Zasshi; 2010 Jun; 130(6):903-10. PubMed ID: 20519870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to Precautionary Guidelines for Compounding Antineoplastic Drugs: A Survey of Nurses and Pharmacy Practitioners.
    Boiano JM; Steege AL; Sweeney MH
    J Occup Environ Hyg; 2015; 12(9):588-602. PubMed ID: 25897702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Criteria and methods for the study of occupational exposure to antineoplastic agents].
    Apostoli P; Clonfero E; Cottica D; Bergamaschi A; Moccaldi R; Draicchio F; Tranfo G; Sannolo N; Sossai D
    Med Lav; 1996; 87(3):230-54. PubMed ID: 8965736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of surface wipe sampling compared to biologic monitoring for occupational exposure to antineoplastic drugs.
    Kibby T
    J Occup Environ Hyg; 2017 Mar; 14(3):159-174. PubMed ID: 27676216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.
    Connor TH; Zock MD; Snow AH
    J Occup Environ Hyg; 2016 Sep; 13(9):658-67. PubMed ID: 27019141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External contamination of antineoplastic drug containers from a Canadian wholesaler.
    Hilliquin D; Bussières JF
    J Oncol Pharm Pract; 2020 Mar; 26(2):423-427. PubMed ID: 31446868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic compounding by IV: Dispensing robot vs. manual compounding in biological safety cabinet.
    Ml H; T W; Jq Z; Yj S; Tj G; Lk Z; J L; Jf Y
    J Oncol Pharm Pract; 2022 Oct; 28(7):1487-1498. PubMed ID: 34162245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk perception and self-assessment of exposure to antineoplastic agents in a group of nurses and pharmacists].
    Vollono C; Badoni G; Petrelli G
    G Ital Med Lav Ergon; 2002; 24(1):49-55. PubMed ID: 11892417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actual conditions of the mixing of antineoplastic drugs for injection in hospitals in Osaka Prefecture, Japan.
    Yoshida J; Kosaka H; Nishida S; Kumagai S
    J Occup Health; 2008; 50(1):86-91. PubMed ID: 18285651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidance values for surface monitoring of antineoplastic drugs in German pharmacies.
    Schierl R; Böhlandt A; Nowak D
    Ann Occup Hyg; 2009 Oct; 53(7):703-11. PubMed ID: 19620232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Work practice and some adverse health effects in nurses handling antineoplastic drugs.
    Krstev S; Perunicić B; Vidaković A
    Med Lav; 2003; 94(5):432-9. PubMed ID: 14619181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device.
    Guillemette A; Langlois H; Voisine M; Merger D; Therrien R; Mercier G; Lebel D; Bussières JF
    J Oncol Pharm Pract; 2014 Dec; 20(6):426-32. PubMed ID: 24395542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective.
    Schulz H; Bigelow S; Dobish R; Chambers CR
    J Oncol Pharm Pract; 2005 Sep; 11(3):101-9. PubMed ID: 16390598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occupational exposure to cytotoxic drugs: the importance of surface cleaning to prevent or minimise exposure.
    Viegas S; Oliveira AC; Carolino E; Pádua M
    Arh Hig Rada Toksikol; 2018 Sep; 69(3):238-249. PubMed ID: 30285944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occupational exposure to antineoplastic drugs in seven Italian hospitals: the effect of quality assurance and adherence to guidelines.
    Turci R; Minoia C; Sottani C; Coghi R; Severi P; Castriotta C; Del Bianco M; Imbriani M
    J Oncol Pharm Pract; 2011 Dec; 17(4):320-32. PubMed ID: 20823049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.
    Viegas S; Pádua M; Veiga AC; Carolino E; Gomes M
    Environ Monit Assess; 2014 Nov; 186(11):7807-18. PubMed ID: 25096642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter study of environmental contamination with antineoplastic drugs in 36 Canadian hospitals: a 2013 follow-up study.
    Berruyer M; Tanguay C; Caron NJ; Lefebvre M; Bussières JF
    J Occup Environ Hyg; 2015; 12(2):87-94. PubMed ID: 25105559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Continuous training program for technicians handling antineoplastic drugs and occupational exposure risk].
    Dussart C; Favier B; Gilles L; Camal I; Almeras D; Latour JF; Grelaud G
    Bull Cancer; 2008 Sep; 95(9):821-2. PubMed ID: 18829414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.